Tag: life sciences
-
Two Covid-19 Vaccines Show Preclinical Immune Responses
Two candidate vaccines to prevent Covid-19 infections show they generate immune protections in lab monkeys, with one vaccine for 13 weeks.
-
Trial Underway for Seasonal Flu Antibody Therapy
A participant in an early-stage clinical trial received the first dose of an experimental synthetic antibody produced in cattle to treat seasonal influenza.
-
Sensor Patch Captures Health Indicators in Sweat
A bio-engineering lab created a wearable fabric patch with threads configured into sensors that capture and measure health indicators from human sweat.
-
Neuro Disease Start-Up Raises $73M in Early Funds
A company developing new therapies for neurodegenerative diseases officially began operations, staked to $73 million raised in its first venture round.
-
Trial Testing Lymphoma Drug to Treat Covid-19
A clinical trial is underway testing an experimental drug for lymphoma and neurological disorders also as a treatment for early Covid-19 infections.
-
Synthetic Protein Maker Raises $91.3M in Venture Funds
A company creating animal-free designer proteins for skin care products is raising more than $91 million in its second venture funding round.
-
Venture Funding Down in 2020, Life Sciences Stay Hot
For the first half of 2020, venture investing declined compared to 2019, but life science and biotechnology investments continued growing for the year.
-
Synthetic Protein Designed to Boost Covid-19 Vaccines
Researchers in Texas designed a synthetic version of a protein found on Covid-19 viruses that can make it easier to produce more vaccines.
-
Advanced Solid Tumor Precision Meds. Trial Begins
A clinical trial is underway testing a treatment for advanced-stage cancers that blocks amino acids allowing nutrients to feed the growth of solid tumors.
-
Trial Testing Point-of-Care Covid-19 Diagnostic
A clinical trial in the U.K. is assessing a testing device to detect Covid-19 viruses in nasal swab samples that returns results in an hour.